A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced Cancer
I4D-MC-JTJF - ClinicalTrials.gov - NCT02124148
The main purpose of this study is to investigate the safety of prexasertib in combination with other anti-cancer drugs (cisplatin, cetuximab, pemetrexed, fluorouracil or LY3023414) in participants with advanced cancer or cancer that has spread to another part of the body. The study has multiple parts (A, B, C, D and E). Participants will only enroll in one part.
Trial Summary
Age Range
≥18 yearsConditions the trial is for
Advanced CancerWhat the trial is testing?
Cetuximab, Leucovorin , Samotolisib, Fluorouracil, Pemetrexed, G-CSF, Prexasertib, CisplatinCould I receive a Placebo?
NoEnrollment Goal
167Trial Dates
Jun 18, 2014 - Feb 13, 2020How long will I be in the trial?
Your participation may continue for as long as you and your study doctor feel that you are benefiting from the study treatment.Trial Phase
ILilly Trial Alerts
Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.
You will complete the questionnaire on another website.YesNo